AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/174
ALTERED EXPRESSION OF INTEFERON-GAMMA AND INTERLEUKIN-4 IN INFLAMMATORY BOWEL-DISEASE
Authors: CAMOGLIO L VELDE AAT TIGGES TJ DAS PK VANDEVENTER SJH
Citation: L. Camoglio et al., ALTERED EXPRESSION OF INTEFERON-GAMMA AND INTERLEUKIN-4 IN INFLAMMATORY BOWEL-DISEASE, Inflammatory bowel diseases, 4(4), 1998, pp. 285-290
TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 INHIBITORS AS MARKERS OF DISEASE-ACTIVITY OF TUBERCULOSIS
Authors: JUFFERMANS NP VERBON A VANDEVENTER SJH VANDEUTEKOM H SPEELMAN P VANDERPOLL T
Citation: Np. Juffermans et al., TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 INHIBITORS AS MARKERS OF DISEASE-ACTIVITY OF TUBERCULOSIS, American journal of respiratory and critical care medicine, 157(4), 1998, pp. 1328-1331
IMMUNOTHERAPY OF CROHNS-DISEASE
Authors: VANMONTFRANS C CAMOGLIO L VANDEVENTER SJH
Citation: C. Vanmontfrans et al., IMMUNOTHERAPY OF CROHNS-DISEASE, Mediators of inflammation, 7(3), 1998, pp. 149-152
VARIATION IN GUT-HOMING CD27-NEGATIVE LYMPHOCYTES IN INFLAMMATORY COLON-DISEASE
Authors: MEENAN J SPAANS J GROOL TA LAMMERS K PALS S TYTGAT GNJ VANDEVENTER SJH
Citation: J. Meenan et al., VARIATION IN GUT-HOMING CD27-NEGATIVE LYMPHOCYTES IN INFLAMMATORY COLON-DISEASE, Scandinavian journal of immunology, 48(3), 1998, pp. 318-323
PHENOTYPICAL CHARACTERIZATION OF CELLS IN THE THORACIC-DUCT OF PATIENTS WITH AND WITHOUT SYSTEMIC INFLAMMATORY RESPONSE SYNDROME AND MULTIPLE ORGAN FAILURE
Authors: LEMAIRE LCJM VANDEVENTER SJH VANLANSCHOT JJB MEENAN J GOUMA DJ
Citation: Lcjm. Lemaire et al., PHENOTYPICAL CHARACTERIZATION OF CELLS IN THE THORACIC-DUCT OF PATIENTS WITH AND WITHOUT SYSTEMIC INFLAMMATORY RESPONSE SYNDROME AND MULTIPLE ORGAN FAILURE, Scandinavian journal of immunology, 47(1), 1998, pp. 69-75
CYTOKINES AND CYTOKINE-BASED THERAPIES
Authors: VANDEVENTER SJH
Citation: Sjh. Vandeventer, CYTOKINES AND CYTOKINE-BASED THERAPIES, Current opinion in gastroenterology, 14(4), 1998, pp. 317-321
ERYTHROMYCIN INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 PRODUCTION INDUCED BY HEAT-KILLED STREPTOCOCCUS-PNEUMONIAE IN WHOLE-BLOOD
Authors: SCHULTZ MJ SPEELMAN P ZAAT S VANDEVENTER SJH VANDERPOLL T
Citation: Mj. Schultz et al., ERYTHROMYCIN INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 PRODUCTION INDUCED BY HEAT-KILLED STREPTOCOCCUS-PNEUMONIAE IN WHOLE-BLOOD, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1605-1609
ANTIINFLAMMATORY EFFECT OF INTERLEUKIN-10 IN RABBIT IMMUNE COMPLEX-INDUCED COLITIS
Authors: GROOL TA VANDULLEMEN H MEENAN J KOSTER F TENKATE FJW LEBEAUT A TYTGAT GNJ VANDEVENTER SJH
Citation: Ta. Grool et al., ANTIINFLAMMATORY EFFECT OF INTERLEUKIN-10 IN RABBIT IMMUNE COMPLEX-INDUCED COLITIS, Scandinavian journal of gastroenterology, 33(7), 1998, pp. 754-758
REDUCTION OF CIRCULATING SECRETORY PHOSPHOLIPASE A(2) LEVELS BY ANTITUMOR NECROSIS FACTOR CHIMERIC MONOCLONAL-ANTIBODY IN PATIENTS WITH SEVERE CROHNS-DISEASE - RELATION BETWEEN TUMOR-NECROSIS-FACTOR AND SECRETORY PHOSPHOLIPASE A(2) IN HEALTHY HUMANS AND IN ACTIVE CROHNS-DISEASE
Authors: VANDULLEMEN HM WOLBINK GJ WEVER PC VANDERPOLL T HACK CE TYTGAT GNJ VANDEVENTER SJH
Citation: Hm. Vandullemen et al., REDUCTION OF CIRCULATING SECRETORY PHOSPHOLIPASE A(2) LEVELS BY ANTITUMOR NECROSIS FACTOR CHIMERIC MONOCLONAL-ANTIBODY IN PATIENTS WITH SEVERE CROHNS-DISEASE - RELATION BETWEEN TUMOR-NECROSIS-FACTOR AND SECRETORY PHOSPHOLIPASE A(2) IN HEALTHY HUMANS AND IN ACTIVE CROHNS-DISEASE, Scandinavian journal of gastroenterology, 33(10), 1998, pp. 1094-1098
LYMPH OF PATIENTS WITH A SYSTEMIC INFLAMMATORY RESPONSE SYNDROME INHIBITS LIPOPOLYSACCHARIDE-INDUCED CYTOKINE PRODUCTION
Authors: LEMAIRE LCJM VANLANSCHOT JJB VANDERPOLL T BUURMAN WA VANDEVENTER SJH GOUMA DJ
Citation: Lcjm. Lemaire et al., LYMPH OF PATIENTS WITH A SYSTEMIC INFLAMMATORY RESPONSE SYNDROME INHIBITS LIPOPOLYSACCHARIDE-INDUCED CYTOKINE PRODUCTION, The Journal of infectious diseases, 178(3), 1998, pp. 883-886
LEVELS OF INHIBITORS OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN URINE AND SERA OF PATIENTS WITH UROSEPSIS
Authors: OLSZYNA DP PRINS JM BUIS B VANDEVENTER SJH SPEELMAN P VANDERPOLL T
Citation: Dp. Olszyna et al., LEVELS OF INHIBITORS OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN URINE AND SERA OF PATIENTS WITH UROSEPSIS, Infection and immunity, 66(8), 1998, pp. 3527-3534
5 GENETIC-MARKERS IN THE INTERLEUKIN-1 FAMILY IN RELATION TO INFLAMMATORY BOWEL-DISEASE
Authors: STOKKERS PCF VANAKEN BE BASOSKI N REITSMA PH TYTGAT GNJ VANDEVENTER SJH
Citation: Pcf. Stokkers et al., 5 GENETIC-MARKERS IN THE INTERLEUKIN-1 FAMILY IN RELATION TO INFLAMMATORY BOWEL-DISEASE, Gut, 43(1), 1998, pp. 33-39
GENETIC-ANALYSIS OF INFLAMMATORY BOWEL-DISEASE IN A LARGE EUROPEAN COHORT SUPPORTS LINKAGE TO CHROMOSOME-12 AND CHROMOSOME-16
Authors: CURRAN ME LAU KF HAMPE J SCHREIBER S BRIDGER S MACPHERSON AJS CARDON LR SAKUL H HARRIS TJR STOKKERS P VANDEVENTER SJH MIRZA M RAEDLER A KRUIS W MECKLER U THEUER D HERRMANN T GIONCHETTI P LEE J MATHEW C LENNARDJONES J
Citation: Me. Curran et al., GENETIC-ANALYSIS OF INFLAMMATORY BOWEL-DISEASE IN A LARGE EUROPEAN COHORT SUPPORTS LINKAGE TO CHROMOSOME-12 AND CHROMOSOME-16, Gastroenterology (New York, N.Y. 1943), 115(5), 1998, pp. 1066-1071
THE THORACIC-DUCT IS NOT A MAJOR ROUTE OF BACTERIAL TRANSLOCATION IN PATIENTS WITH MULTIPLE ORGAN FAILURE
Authors: LEMAIRE LCJM VANLANSCHOT JJB STOUTENBEEK CP VANDEVENTER SJH DANKERT J GOUMA DJ
Citation: Lcjm. Lemaire et al., THE THORACIC-DUCT IS NOT A MAJOR ROUTE OF BACTERIAL TRANSLOCATION IN PATIENTS WITH MULTIPLE ORGAN FAILURE, Gastroenterology, 114(4), 1998, pp. 138-138
PLASMA AND LYMPH OF PATIENTS WITH AND WITHOUT MULTIPLE ORGAN FAILURE INHIBIT ENDOTOXIN-INDUCED CYTOKINE RELEASE
Authors: LEMAIRE LCJM VANDERPOLL T VANLANSCHOT JJB BUURMAN WA VANDEVENTER SJH GOUMA DJ
Citation: Lcjm. Lemaire et al., PLASMA AND LYMPH OF PATIENTS WITH AND WITHOUT MULTIPLE ORGAN FAILURE INHIBIT ENDOTOXIN-INDUCED CYTOKINE RELEASE, Gastroenterology, 114(4), 1998, pp. 364-364
A SHIFT OF LIPOPROTEIN BOUND ENDOTOXIN IN BILE-DUCT LIGATED RATS
Authors: SEWNATH ME LEVELS JHM VANDEVENTER SJH MAAS MAW ELFERINK RPJO ABRAHAMS PR GOUMA DJ
Citation: Me. Sewnath et al., A SHIFT OF LIPOPROTEIN BOUND ENDOTOXIN IN BILE-DUCT LIGATED RATS, Gastroenterology, 114(4), 1998, pp. 579-579
DOES URSODEOXYCHOLIC ACID MEDIATE IMMUNO-MODULATORY AND ANTIINFLAMMATORY EFFECTS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
Authors: VANMILLIGENDEWIT AW KUIPER H CAMOGLIO L VANBRACHT J JONES EA TYTGAT GNJ VANDEVENTER SJH
Citation: Aw. Vanmilligendewit et al., DOES URSODEOXYCHOLIC ACID MEDIATE IMMUNO-MODULATORY AND ANTIINFLAMMATORY EFFECTS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS, Gastroenterology, 114(4), 1998, pp. 657-657
GENETIC-ANALYSIS OF INFLAMMATORY BOWEL-DISEASE IN A LARGE EUROPEAN PATIENT POPULATION SUPPORTS LINKAGE TO HUMAN-CHROMOSOME-12 AND HUMAN-CHROMOSOME-16
Authors: CURRAN ME LAU KF CARDON L SAKUL H HARRIS TJR HAMPE J SCHREIBER S STOCKKERS P VANDEVENTER SJH RAEDLER A KRUIS W KNOFLACH P WEWALKA P GIONCHETTI P BRIDGER S MACPHERSON AJS MIRZA M MATHEW C LEE J JONES JL
Citation: Me. Curran et al., GENETIC-ANALYSIS OF INFLAMMATORY BOWEL-DISEASE IN A LARGE EUROPEAN PATIENT POPULATION SUPPORTS LINKAGE TO HUMAN-CHROMOSOME-12 AND HUMAN-CHROMOSOME-16, Gastroenterology, 114(4), 1998, pp. 3925-3925
ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY (CA2) PRODUCES ENDOSCOPIC HEALING IN PATIENTS WITH TREATMENT-RESISTANT, ACTIVE CROHNS-DISEASE
Authors: DHAENS GR VANDEVENTER SJH VANHOGEZAND R CHALMERS DM BRAAKMAN TAJ SCHAIBLE TF RUTGEERTS PJ
Citation: Gr. Dhaens et al., ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY (CA2) PRODUCES ENDOSCOPIC HEALING IN PATIENTS WITH TREATMENT-RESISTANT, ACTIVE CROHNS-DISEASE, Gastroenterology, 114(4), 1998, pp. 3951-3951
SAFETY, TOLERANCE AND EFFICACY OF MULTIPLE DOSES OF SUBCUTANEOUS INTERLEUKIN-10 IN MILD-TO-MODERATE ACTIVE CROHNS-DISEASE (STAMM-CD)
Authors: FEDORAK RN GANGL A ELSON CO RUTGEERTS P SCHREIBER S WILD G HANAUER S VANDEVENTER SJH GRINT P
Citation: Rn. Fedorak et al., SAFETY, TOLERANCE AND EFFICACY OF MULTIPLE DOSES OF SUBCUTANEOUS INTERLEUKIN-10 IN MILD-TO-MODERATE ACTIVE CROHNS-DISEASE (STAMM-CD), Gastroenterology, 114(4), 1998, pp. 3993-3993
CURRENT DRUG-TREATMENT STRATEGIES FOR DISSEMINATED INTRAVASCULAR COAGULATION
Authors: DEJONGE E LEVI M STOUTENBEEK CP VANDEVENTER SJH
Citation: E. Dejonge et al., CURRENT DRUG-TREATMENT STRATEGIES FOR DISSEMINATED INTRAVASCULAR COAGULATION, Drugs, 55(6), 1998, pp. 767-777
HIGH-PERFORMANCE GEL CHROMATOGRAPHY (HPGC) FOR THE ANALYSIS OF LIPOPROTEIN ASSOCIATED ENDOTOXIN
Authors: LEVELS JHM ABRAHAM PR VANDEVENTER SJH VANDENENDE A
Citation: Jhm. Levels et al., HIGH-PERFORMANCE GEL CHROMATOGRAPHY (HPGC) FOR THE ANALYSIS OF LIPOPROTEIN ASSOCIATED ENDOTOXIN, Clinical chemistry, 44, 1998, pp. 356-356
ENDOTOXIN RELEASE AND CYTOKINE PRODUCTION IN ACUTE AND CHRONIC MENINGOCOCCEMIA
Authors: PRINS JM LAUW FN DERKX BHF SPEELMAN P KUIJPER EJ DANKERT J VANDEVENTER SJH
Citation: Jm. Prins et al., ENDOTOXIN RELEASE AND CYTOKINE PRODUCTION IN ACUTE AND CHRONIC MENINGOCOCCEMIA, Clinical and experimental immunology, 114(2), 1998, pp. 215-219
PROCOAGULANT AND PROINFLAMMATORY ACTIVITY IN ACUTE CORONARY SYNDROMES
Authors: MANTEN A DEWINTER RJ MINNEMA MC TENCATE H LIJMER JG ADAMS R PETERS RJG VANDEVENTER SJH
Citation: A. Manten et al., PROCOAGULANT AND PROINFLAMMATORY ACTIVITY IN ACUTE CORONARY SYNDROMES, Cardiovascular Research, 40(2), 1998, pp. 389-395
ACTIVATION OF CLOTTING FACTOR-XI WITHOUT DETECTABLE CONTACT ACTIVATION IN EXPERIMENTAL HUMAN ENDOTOXEMIA
Authors: MINNEMA MC PAJKRT D WUILLEMIN WA ROEM D BLEEKER WK LEVI M VANDEVENTER SJH HACK CE TENCATE H
Citation: Mc. Minnema et al., ACTIVATION OF CLOTTING FACTOR-XI WITHOUT DETECTABLE CONTACT ACTIVATION IN EXPERIMENTAL HUMAN ENDOTOXEMIA, Blood, 92(9), 1998, pp. 3294-3301
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>